Monday, 27 December 2010

Belga S




Belga S may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Belga S



Ronidazole

Ronidazole is reported as an ingredient of Belga S in the following countries:


  • Netherlands

International Drug Name Search

Monday, 20 December 2010

Alendronato Ranbaxy




Alendronato Ranbaxy may be available in the countries listed below.


Ingredient matches for Alendronato Ranbaxy



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendronato Ranbaxy in the following countries:


  • Italy

International Drug Name Search

Saturday, 18 December 2010

Doxepin




In some countries, this medicine may only be approved for veterinary use.


In the US, Doxepin (doxepin systemic) is a member of the following drug classes: miscellaneous anxiolytics, sedatives and hypnotics, tricyclic antidepressants and is used to treat Anxiety, Depression, Insomnia, Irritable Bowel Syndrome, Reflex Sympathetic Dystrophy Syndrome and Urticaria.

US matches:

  • Doxepin

  • Doxepin Capsules

  • Doxepin Concentrate

  • Doxepin Cream

  • Doxepin Topical

  • Doxepin Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06AA12

CAS registry number (Chemical Abstracts Service)

0001668-19-5

Chemical Formula

C19-H21-N-O

Molecular Weight

279

Therapeutic Category

Antidepressant, tricyclic

Chemical Name

1-Propanamine, 3-dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-

Foreign Names

  • Doxepinum (Latin)
  • Doxepin (German)
  • Doxépine (French)
  • Doxepina (Spanish)

Generic Names

  • Doxepin (OS: BAN)
  • Doxepina (OS: DCIT)
  • Doxépine (OS: DCF)
  • MF 10 (IS)
  • Doxepin Hydrochloride (OS: USAN, BANM)
  • MF 110 (IS)
  • P 3693 A (IS)
  • Doxepin Hydrochloride (PH: BP 2010, USP 32, Ph. Eur. 6)
  • Doxépine (chlorhydrate de) (PH: Ph. Eur. 6)
  • Doxepinhydrochlorid (PH: Ph. Eur. 6)
  • Doxepini hydrochloridum (PH: Ph. Eur. 6)

Brand Names

  • Sinequan
    Pfizer, Norway


  • Sinequan (veterinary use)
    Pfizer Animal Health, United Kingdom


  • Spectra
    Solus, India


  • Anten
    Pacific, New Zealand


  • Apo-Doxepin
    Apotex, Canada


  • Aponal
    Cheplapharm, Germany


  • Deptran
    Alphapharm, Australia


  • Doneurin
    Hexal, Germany; Hexal, Luxembourg


  • Doxal
    Orion, Finland


  • Doxe TAD
    TAD, Germany


  • Doxepin AL
    Aliud, Germany


  • Doxepin beta
    Betapharm, Germany


  • Doxepin dura
    Mylan dura, Germany


  • Doxepin Holsten
    Holsten, Germany


  • Doxepin Hydrochloride
    Morton Grove, United States; Mylan, United States; Par, United States; Pharmaceutical Associates, United States; Silarx, United States; Teva USA, United States; Watson, United States


  • Doxepin Lindo
    Lindopharm, Germany


  • Doxepin Sandoz
    Sandoz, Germany


  • Doxepin Stada
    Stada, Germany


  • Doxepin Sunve
    Sunve, China


  • Doxepin
    Pliva, Lithuania; Pliva, Poland; Polfa Kutno, Poland; Terapia, Romania


  • Doxepin-1A Pharma
    1A Pharma, Germany


  • Doxepin-biomo
    Biomo, Germany


  • Doxepin-neuraxpharm
    Neuraxpharm, Germany


  • Doxepin-ratiopharm
    Ratiopharm, Germany


  • Doxepin-RPh
    Lach, Germany


  • Espadox
    Esparma, Germany


  • Expan
    Psipharma, Colombia


  • Gilex
    Rekah, Israel


  • Ichderm
    Lotus, Taiwan


  • Mareen
    Krewel, Germany


  • Quitaxon
    Nepalm, France


  • Sagalon
    Surya Dermato Medica, Indonesia


  • Silenor
    Somaxon Pharmaceuticals, United States


  • Sinepin
    Marlborough, United Kingdom


  • Sinequan
    Alkaloid, Bosnia & Herzegowina; Alkaloid, Slovenia; Farmasierra, Spain; Pfizer, Australia; Pfizer, Belgium; Pfizer, Greece; Pfizer, Guyana; Pfizer, Hong Kong; Pfizer, Luxembourg; Pfizer, Netherlands; Pfizer, Poland; Pfizer, Thailand; Pfizer, Taiwan; Pfizer, United States


  • Sinquan
    Pfizer, Switzerland; Pfizer, Denmark; Pfizer, Iceland


  • Xepin
    Cambridge Healthcare, United Kingdom


  • Zonalon
    Nycomed, United States; Rafa, Israel

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 17 December 2010

Lorid




Lorid may be available in the countries listed below.


Ingredient matches for Lorid



Loratadine

Loratadine is reported as an ingredient of Lorid in the following countries:


  • Russian Federation

International Drug Name Search

Thursday, 16 December 2010

Amoxicilline Aurobindo




Amoxicilline Aurobindo may be available in the countries listed below.


Ingredient matches for Amoxicilline Aurobindo



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilline Aurobindo in the following countries:


  • Netherlands

International Drug Name Search

Bifokey




Bifokey may be available in the countries listed below.


Ingredient matches for Bifokey



Bifonazole

Bifonazole is reported as an ingredient of Bifokey in the following countries:


  • Spain

International Drug Name Search

Wednesday, 15 December 2010

Loratadin Helvepharm




Loratadin Helvepharm may be available in the countries listed below.


Ingredient matches for Loratadin Helvepharm



Loratadine

Loratadine is reported as an ingredient of Loratadin Helvepharm in the following countries:


  • Switzerland

International Drug Name Search

Sunday, 12 December 2010

Suprapen




Suprapen may be available in the countries listed below.


Ingredient matches for Suprapen



Amoxicillin

Amoxicillin is reported as an ingredient of Suprapen in the following countries:


  • South Africa

Flucloxacillin

Flucloxacillin is reported as an ingredient of Suprapen in the following countries:


  • South Africa

International Drug Name Search

Wednesday, 8 December 2010

Algimesil




Algimesil may be available in the countries listed below.


Ingredient matches for Algimesil



Nimesulide

Nimesulide is reported as an ingredient of Algimesil in the following countries:


  • Italy

International Drug Name Search

Monday, 6 December 2010

Oxibuprocaina




Oxibuprocaina may be available in the countries listed below.


Ingredient matches for Oxibuprocaina



Oxybuprocaine

Oxibuprocaina (DCIT) is also known as Oxybuprocaine (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 5 December 2010

Amoxicilline Panpharma




Amoxicilline Panpharma may be available in the countries listed below.


Ingredient matches for Amoxicilline Panpharma



Amoxicillin

Amoxicillin sodium salt (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilline Panpharma in the following countries:


  • France

International Drug Name Search

Friday, 3 December 2010

AAA




AAA may be available in the countries listed below.


UK matches:

  • AAA Sore Throat Spray (SPC)

Ingredient matches for AAA



Benzocaine

Benzocaine is reported as an ingredient of AAA in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Eltenac




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0072895-88-6

Chemical Formula

C12-H9-Cl2-N-O2-S

Molecular Weight

302

Therapeutic Categories

Analgesic, antipyretic and anti-inflammatory agent

Non-steroidal anti-inflammatory drug, NSAID

Chemical Name

4-(2,6-Dichloroanilino)-3-thiopheneacetic acid

Foreign Names

  • Eltenacum (Latin)
  • Eltenac (German)
  • Elténac (French)
  • Eltenaco (Spanish)

Brand Name

  • Telzenac (veterinary use)
    Schering-Plough Veterinary, United Kingdom

International Drug Name Search

Glossary

Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 2 December 2010

Otrivine Child




Otrivine Child may be available in the countries listed below.


UK matches:

  • Otrivine Child Nasal Drops (SPC)

Ingredient matches for Otrivine Child



Xylometazoline

Xylometazoline hydrochloride (a derivative of Xylometazoline) is reported as an ingredient of Otrivine Child in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 28 November 2010

Fotil




Fotil may be available in the countries listed below.


Ingredient matches for Fotil



Pilocarpine

Pilocarpine hydrochloride (a derivative of Pilocarpine) is reported as an ingredient of Fotil in the following countries:


  • Austria

  • Bahrain

  • Denmark

  • Germany

  • Greece

  • Norway

  • Sweden

Timolol

Timolol maleate (a derivative of Timolol) is reported as an ingredient of Fotil in the following countries:


  • Austria

  • Bahrain

  • Denmark

  • Georgia

  • Greece

  • Iceland

  • Norway

  • Sweden

International Drug Name Search

Saturday, 27 November 2010

Alendronat acis




Alendronat acis may be available in the countries listed below.


Ingredient matches for Alendronat acis



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendronat acis in the following countries:


  • Germany

International Drug Name Search

Alfuzosin




In the US, Alfuzosin (alfuzosin systemic) is a member of the drug class antiadrenergic agents, peripherally acting and is used to treat Benign Prostatic Hyperplasia.

US matches:

  • Alfuzosin

  • Alfuzosin Hydrochloride

UK matches:

  • Alfuzosin Hydrochloride 2.5mg Tablets

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G04CA01

CAS registry number (Chemical Abstracts Service)

0081403-80-7

Chemical Formula

C19-H27-N5-O4

Molecular Weight

389

Therapeutic Categories

Antihypertensive agent

α-Adrenergic blocking agent

Chemical Name

2-Furancarboxamide, N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-

Foreign Names

  • Alfuzosinum (Latin)
  • Alfuzosin (German)
  • Alfuzosine (French)
  • Alfuzosina (Spanish)

Generic Names

  • Alfuzosin (OS: BAN)
  • Alfuzosina (OS: DCIT)
  • Alfuzosine (OS: DCF)
  • Alfuzosin Hydrochloride (OS: BANM, USAN)
  • SL 77499-10 (IS: Synthélabo)
  • Alfuzosin Hydrochloride (PH: BP 2010, Ph. Eur. 6, USP 32)
  • Alfuzosine (chlorhydrate d') (PH: Ph. Eur. 6)
  • Alfuzosinhydrochlorid (PH: Ph. Eur. 6)
  • Alfuzosini hydrochloridum (PH: Ph. Eur. 6)

Brand Names

  • Alcinin
    Pharmathen, Greece


  • Alfuzosin Teva
    Teva, Lithuania


  • Alfuzosina Ciclum
    Ciclum, Portugal


  • Alfuzosina Sandoz
    Sandoz, Portugal


  • Dalfaz
    Sanofi-Aventis, Argentina


  • Flotral
    Ranbaxy, India; Ranbaxy, Peru


  • Xantral
    Sanofi-Synthelabo, Peru


  • Xatral SR
    Sanofi-Aventis, Australia; Sanofi-Aventis, Lithuania


  • Xatral
    Sanofi Aventis, Tunisia


  • Zatral
    Eskayef, Bangladesh


  • Alfetim
    Sanofi-Aventis, Hungary


  • Alfu
    Rowex, Ireland


  • Alfugen
    Generics, Hungary


  • AlfuHexal
    Hexal, Poland


  • AlfuLEK
    Lek, Poland


  • Alfunar
    Apogepha, Germany


  • Alfural
    Pekit, Greece


  • Alfusin
    TAD, Germany


  • Alfusozina
    Grey Inversiones, Peru


  • AlfuTeva
    Teva, Poland


  • Alfuzin
    Biomedica-Chemica, Greece


  • Alfuzosin 1A Pharma
    1A Pharma, Poland


  • Alfuzosin 1A-Pharma
    1A Farma, Denmark; 1A Pharma, Austria; 1A Pharma, Germany


  • Alfuzosin AbZ
    AbZ, Germany


  • Alfuzosin Actavis
    Actavis, Switzerland; Actavis, Sweden


  • Alfuzosin AL
    Aliud, Germany


  • Alfuzosin Arcana
    Arcana, Austria


  • Alfuzosin Axapharm
    Axapharm, Switzerland


  • Alfuzosin beta
    Betapharm, Germany


  • Alfuzosin Copyfarm
    Copyfarm, Denmark


  • Alfuzosin Generics
    Generics, Greece


  • Alfuzosin Hexal
    Hexal, Austria; Hexal, Germany; Sandoz, Czech Republic; Sandoz, Sweden


  • Alfuzosin Hydrochlorid Winthrop
    Sanofi-Aventis, Finland


  • Alfuzosin Mylan
    Generics, Slovakia


  • Alfuzosin Norma
    Norma, Greece


  • Alfuzosin Pliva
    Pliva, Croatia (Hrvatska)


  • Alfuzosin ratiopharm
    Ratiopharm, Sweden


  • Alfuzosin Sandoz
    Sandoz, Switzerland; Sandoz, Germany; Sandoz, Denmark; Sandoz, Hungary; Sandoz, Slovakia


  • Alfuzosin Stada
    Stada, Austria; Stada, Germany; Stada, Denmark; Stada, Sweden


  • Alfuzosin T
    Pliva, Slovakia


  • Alfuzosin Teva
    Teva, Latvia; Teva Pharma, Switzerland


  • Alfuzosin Winthrop
    Sanofi-Aventis, Denmark; Sanofi-Aventis, Sweden; Winthrop, Germany


  • Alfuzosina Bexal
    Bexal, Spain


  • Alfuzosina DOC
    DOC Generici, Italy


  • Alfuzosina EG
    EG, Italy


  • Alfuzosina Hexal
    Hexal, Italy


  • Alfuzosina Mepha
    Mepha, Portugal


  • Alfuzosina Merck
    Merck, Portugal; Merck Genericos, Spain


  • Alfuzosina Mylan
    Mylan, Italy


  • Alfuzosina ratiopharm
    Ratiopharm, Spain; Ratiopharm, Italy; Ratiopharm, Portugal


  • Alfuzosina Sandoz
    Sandoz, Spain; Sandoz, Italy


  • Alfuzosina Stada
    Stada, Spain


  • Alfuzosina Teva
    Teva, Italy


  • Alfuzosina Ur
    Uso Racional, Spain


  • Alfuzosina Winthrop
    Winthrop, Italy; Winthrop, Portugal


  • Alfuzosin-Acino
    Acino, Germany


  • Alfuzosin-Cimex
    Cimex, Switzerland


  • Alfuzosin-CT
    CT Arzneimittel, Germany


  • Alfuzosin-dura
    Mylan dura, Germany


  • Alfuzosine Biogaran
    Biogaran, France


  • Alfuzosine EG L.P.
    EG Labo, France


  • Alfuzosine HCI Ratiopharm
    ratiopharm, Netherlands


  • Alfuzosine HCL A
    Apothecon, Netherlands


  • Alfuzosine HCl Actavis
    Actavis, Netherlands


  • Alfuzosine HCl CF
    Centrafarm, Netherlands


  • Alfuzosine HCL Mylan
    Mylan, Belgium; Mylan, Netherlands


  • Alfuzosine HCl PCH
    Pharmachemie, Netherlands


  • Alfuzosine HCL Sandoz
    Sandoz, Netherlands


  • Alfuzosine Mylan L.P.
    Mylan, France


  • Alfuzosine Qualimed L.P.
    Qualimed, France


  • Alfuzosine Ranbaxy L.P.
    Ranbaxy, France; Ranbaxy, Netherlands


  • Alfuzosine Ratiopharm L.P.
    Ratiopharm, France


  • Alfuzosine Sandoz L.P.
    Sandoz, Belgium; Sandoz, France


  • Alfuzosine Teva L.P.
    Teva Santé, France


  • Alfuzosine Uno Winthrop
    Sanofi-Aventis, Switzerland


  • Alfuzosine Winthrop
    Sanofi-Aventis, France; Sanofi-Aventis S.A., Spain


  • Alfuzosine Zydus L.P.
    Zydus, France


  • Alfuzosine
    Sanofi-Aventis, Netherlands; Stada, Netherlands


  • Alfuzosin-Mepha
    Mepha Pharma, Switzerland


  • Alfuzosin-ratiopharm
    Ratiopharm, Germany; Ratiopharm, Denmark


  • Alfuzostad
    Stada, Czech Republic; Stada, Hungary; Stada, Poland; Stada, Slovakia


  • Alreos
    Teva, Poland


  • Alugen
    Generics, Poland


  • Apo-Alfuzosin
    Apotex, Canada


  • Benestan
    Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal; Sanofi-Aventis S.A., Spain


  • Cezin
    Farmacom, Poland


  • Dalfaz Uno
    Sanofi-Aventis, Poland


  • Dalfaz
    Sanofi-Aventis, Georgia; Sanofi-Aventis, Poland; Sanofi-Aventis, Russian Federation


  • Dazular XL
    Tillomed, United States


  • Innosensitive
    Faran Laboratories, Greece


  • Lafunomyl
    Mylan, Sweden


  • Mittoval
    Sanofi-Aventis, Italy


  • Ofuxal
    Specifar, Greece


  • Tevax
    Teva, Ireland


  • Unibenestan
    Sanofi-Aventis S.A., Spain


  • Union Uno
    Sanofi-Synthelabo, Luxembourg


  • Urion
    Sanofi-Aventis, Germany; Sanofi-Synthelabo, Luxembourg; Zambon, France


  • Uroxatral
    Sanofi-Aventis, Argentina; Sanofi-Aventis, Chile; Sanofi-Aventis, Germany; Sanofi-Aventis, United States


  • Xatger
    Gerard, Ireland


  • Xatral XL
    Sanofi-Aventis, Taiwan


  • Xatral
    Sanofi-Aventis, Austria; Sanofi-Aventis, Belgium; Sanofi-Aventis, Burkina Faso; Sanofi-Aventis, Benin; Sanofi-Aventis, Brazil; Sanofi-Aventis, Canada; Sanofi-Aventis, Congo; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Cote D'ivoire; Sanofi-Aventis, Cameroon; Sanofi-Aventis, Colombia; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Denmark; Sanofi-Aventis, Dominican Republic; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Estonia; Sanofi-Aventis, Finland; Sanofi-Aventis, France; Sanofi-Aventis, Gabon; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Georgia; Sanofi-Aventis, Guinea; Sanofi-Aventis, Guatemala; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Honduras; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Ireland; Sanofi-Aventis, Israel; Sanofi-Aventis, Italy; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Madagascar; Sanofi-Aventis, Mali; Sanofi-Aventis, Malta; Sanofi-Aventis, Mauritius; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Niger; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Norway; Sanofi-Aventis, Oman; Sanofi-Aventis, Philippines; Sanofi-Aventis, Romania; Sanofi-Aventis, Serbia; Sanofi-Aventis, Singapore; Sanofi-Aventis, Slovakia; Sanofi-Aventis, Senegal; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Chad; Sanofi-Aventis, Togo; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Venezuela; Sanofi-Aventis, Vietnam; Sanofi-Aventis, South Africa; Sanofi-Aventis, Zaire; Sanofi-Synthelabo, Greece; Sanofi-Synthelabo, Luxembourg; Sanofi-Synthelabo, Panama


  • Xatral OD
    Sanofi-Aventis, Sweden


  • Xatral Uno
    Sanofi-Aventis, Switzerland; Sanofi-Synthelabo, Iceland; Sanofi-Synthelabo, Luxembourg

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 20 November 2010

Amoclav 1a Pharma




Amoclav 1a Pharma may be available in the countries listed below.


Ingredient matches for Amoclav 1a Pharma



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoclav 1a Pharma in the following countries:


  • Hungary

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoclav 1a Pharma in the following countries:


  • Hungary

International Drug Name Search

Atenolol / Chlorthalidone Sandoz




Atenolol / Chlorthalidone Sandoz may be available in the countries listed below.


Ingredient matches for Atenolol / Chlorthalidone Sandoz



Atenolol

Atenolol is reported as an ingredient of Atenolol / Chlorthalidone Sandoz in the following countries:


  • Netherlands

Chlortalidone

Chlortalidone is reported as an ingredient of Atenolol / Chlorthalidone Sandoz in the following countries:


  • Netherlands

International Drug Name Search

Wednesday, 10 November 2010

Fleet




Fleet may be available in the countries listed below.


Ingredient matches for Fleet



Sodium Phosphate

Sodium Phosphate Dibasic (a derivative of Sodium Phosphate) is reported as an ingredient of Fleet in the following countries:


  • Ireland

International Drug Name Search

Monday, 8 November 2010

Dontisolon




Dontisolon may be available in the countries listed below.


Ingredient matches for Dontisolon



Prednisolone

Prednisolone is reported as an ingredient of Dontisolon in the following countries:


  • Germany

Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Dontisolon in the following countries:


  • Germany

International Drug Name Search

Sunday, 7 November 2010

Fentanyl DeltaSelect




Fentanyl DeltaSelect may be available in the countries listed below.


Ingredient matches for Fentanyl DeltaSelect



Fentanyl

Fentanyl citrate (a derivative of Fentanyl) is reported as an ingredient of Fentanyl DeltaSelect in the following countries:


  • Germany

International Drug Name Search

Kiltix




Kiltix may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Kiltix



Flumethrin

Flumethrin is reported as an ingredient of Kiltix in the following countries:


  • France

  • Germany

  • Luxembourg

  • Portugal

Propoxur

Propoxur is reported as an ingredient of Kiltix in the following countries:


  • France

  • Germany

  • Luxembourg

  • Portugal

International Drug Name Search

Thursday, 28 October 2010

Demerol




In the US, Demerol (meperidine systemic) is a member of the drug class narcotic analgesics and is used to treat Light Sedation and Pain.

US matches:

  • Demerol

  • Demerol Syrup

  • Demerol Tablets

  • Demerol HCl

  • Demerol Injection

Ingredient matches for Demerol



Pethidine

Pethidine hydrochloride (a derivative of Pethidine) is reported as an ingredient of Demerol in the following countries:


  • Canada

  • Chile

  • Philippines

  • United States

  • Venezuela

International Drug Name Search

Wednesday, 27 October 2010

Prednesol




Prednesol may be available in the countries listed below.


Ingredient matches for Prednesol



Prednisolone

Prednisolone 21-(disodium phosphate) (a derivative of Prednisolone) is reported as an ingredient of Prednesol in the following countries:


  • Ireland

International Drug Name Search

Monukast




Monukast may be available in the countries listed below.


Ingredient matches for Monukast



Montelukast

Montelukast is reported as an ingredient of Monukast in the following countries:


  • Venezuela

International Drug Name Search

Monday, 25 October 2010

Criax




Criax may be available in the countries listed below.


Ingredient matches for Criax



Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Criax in the following countries:


  • Indonesia

International Drug Name Search

Friday, 22 October 2010

Apo-Sulin




Apo-Sulin may be available in the countries listed below.


Ingredient matches for Apo-Sulin



Sulindac

Sulindac is reported as an ingredient of Apo-Sulin in the following countries:


  • Canada

  • Peru

  • Singapore

International Drug Name Search

Tuesday, 19 October 2010

Pyrantel Pamoate




Ingredient matches for Pyrantel Pamoate



Pyrantel

Pyrantel Pamoate (JAN, USAN) is known as Pyrantel in the US.

International Drug Name Search

Glossary

JANJapanese Accepted Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 17 October 2010

Claridar




Claridar may be available in the countries listed below.


Ingredient matches for Claridar



Clarithromycin

Clarithromycin is reported as an ingredient of Claridar in the following countries:


  • Bahrain

  • Iraq

  • Jordan

  • Kuwait

  • Lebanon

  • Libya

  • Nigeria

  • Oman

  • Qatar

  • Saudi Arabia

  • Somalia

  • Sudan

  • United Arab Emirates

  • Yemen

International Drug Name Search

Thursday, 7 October 2010

Amoxicilline / Acide Clavulanique Mylan Adultes




Amoxicilline/Acide Clavulanique Mylan Adultes may be available in the countries listed below.


Ingredient matches for Amoxicilline/Acide Clavulanique Mylan Adultes



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilline/Acide Clavulanique Mylan Adultes in the following countries:


  • France

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoxicilline/Acide Clavulanique Mylan Adultes in the following countries:


  • France

International Drug Name Search

Tuesday, 5 October 2010

Ambrol




Ambrol may be available in the countries listed below.


Ingredient matches for Ambrol



Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Ambrol in the following countries:


  • Turkey

International Drug Name Search

Monday, 4 October 2010

Albina




Albina may be available in the countries listed below.


Ingredient matches for Albina



Aminophylline

Aminophylline is reported as an ingredient of Albina in the following countries:


  • Japan

International Drug Name Search

Sunday, 3 October 2010

Opticort




Opticort may be available in the countries listed below.


Ingredient matches for Opticort



Dexamethasone

Dexamethasone is reported as an ingredient of Opticort in the following countries:


  • Peru

International Drug Name Search

Amoxifur




Amoxifur may be available in the countries listed below.


Ingredient matches for Amoxifur



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxifur in the following countries:


  • Mexico

International Drug Name Search

Saturday, 2 October 2010

Diasef




Diasef may be available in the countries listed below.


Ingredient matches for Diasef



Glipizide

Glipizide is reported as an ingredient of Diasef in the following countries:


  • Hong Kong

  • Singapore

International Drug Name Search

Friday, 1 October 2010

Amoxicillina Tiidrato




Amoxicillina Tiidrato may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Amoxicillina Tiidrato



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillina Tiidrato in the following countries:


  • Italy

International Drug Name Search

Cefmetazole




In the US, Cefmetazole is a member of the drug class second generation cephalosporins and is used to treat Cesarean Section, Hysterectomy and Surgical Prophylaxis.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01DC09

CAS registry number (Chemical Abstracts Service)

0056796-20-4

Chemical Formula

C15-H17-N7-O5-S3

Molecular Weight

471

Therapeutic Category

Antibacterial: Cephalosporin

Chemical Name

(6R,7R)-7-[2-[(Cyanomethyl)thio]acetamido]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

Foreign Names

  • Cefmetazolum (Latin)
  • Cefmetazol (German)
  • Cefmétazole (French)
  • Cefmetazol (Spanish)

Generic Names

  • Cefmetazole (OS: USAN)
  • CS 1170 (IS: Sankyo)
  • SKF 83088 (IS: SmithklineFr)
  • U 72791 (IS: Upjohn)
  • Cefmetazole (PH: USP 32)
  • Cefmetazole Sodium (OS: USAN, JAN)
  • U 72791 A (IS: Upjohn)
  • Cefmetazole Sodium (PH: USP 32, JP XV)

Brand Names

  • Cefmetazole
    Nipro PharmaNipurofama, Japan


  • Cefmetazon
    Daiichi, Taiwan; Daiichi Sankyo, China; Daiichi Sankyo, Japan


  • Cefultol
    Taiyo Pharmaceutical, Japan


  • Ceprametacin
    Shiono Kemikaru, Japan


  • Metacin
    TTY Biopharm, Taiwan


  • Metafar
    Lafare, Italy


  • Metax
    C&G, Italy


  • Piretazol
    Nichi-Iko PharmaceuticalJMA, Japan


  • Qizol
    Ethica Industri Farmasi, Indonesia


  • Riliajin
    Towa Yakuhin, Japan


  • Tokiozole
    Isei, Japan

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 26 September 2010

Bentonite




In some countries, this medicine may only be approved for veterinary use.

Scheme

NF

CAS registry number (Chemical Abstracts Service)

0001302-78-9

Therapeutic Categories

Pharmaceutic aid

Astringent agent

Foreign Names

  • Bentonitum (Latin)
  • Bentonit (German)
  • Bentonite (French)
  • Bentonita (Spanish)

Generic Names

  • Bentonite (OS: JAN, DCF)
  • Aluminiumsilicat-4 (IS)
  • CCRIS 3663 (IS)
  • E558 (IS)
  • Mineral soap (IS)
  • Pigment white 19 (IS)
  • Soap clay (IS)
  • Wilkinite (IS)
  • Bentonite (PH: Ph. Eur. 6, BP 2010, Ph. Int. 4, NF 27, JP XV)

Brand Names

  • Bentonitum
    IFET, Greece


  • Peptosyl (Bentonite andBismuth subsalicylate (veterinary use))
    Vetpharm, New Zealand

International Drug Name Search

Glossary

DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
NFThe National Formulary (USA)
OSOfficial Synonym
PHPharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Chlordiazepoxide and Amitriptyline hydrochloride




Ingredient matches for Chlordiazepoxide and Amitriptyline hydrochloride



Amitriptyline

Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Chlordiazepoxide and Amitriptyline hydrochloride in the following countries:


  • United States

Chlordiazepoxide

Chlordiazepoxide is reported as an ingredient of Chlordiazepoxide and Amitriptyline hydrochloride in the following countries:


  • United States

International Drug Name Search

Tuesday, 21 September 2010

Amfotericina B




Amfotericina B may be available in the countries listed below.


Ingredient matches for Amfotericina B



Amphotericin B

Amfotericina B (DCIT) is known as Amphotericin B in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 17 September 2010

Griseofulvine




Griseofulvine may be available in the countries listed below.


Ingredient matches for Griseofulvine



Griseofulvin

Griseofulvin is reported as an ingredient of Griseofulvine in the following countries:


  • Tunisia

International Drug Name Search

Thursday, 16 September 2010

Domper-M




Domper-M may be available in the countries listed below.


Ingredient matches for Domper-M



Domperidone

Domperidone maleate (a derivative of Domperidone) is reported as an ingredient of Domper-M in the following countries:


  • Thailand

International Drug Name Search

desloratadine


des-lor-A-ta-deen


Commonly used brand name(s)

In the U.S.


  • Clarinex

  • Clarinex Reditabs

Available Dosage Forms:


  • Tablet, Disintegrating

  • Tablet

  • Syrup

Therapeutic Class: Respiratory Agent


Pharmacologic Class: Antihistamine, Less-Sedating


Chemical Class: Piperidine


Uses For desloratadine


Desloratadine is an antihistamine. It is used to relieve the symptoms of hay fever and hives of the skin.


Antihistamines work by preventing the effects of a substance called histamine, which is produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes. Also, in some persons histamine can close up the bronchial tubes (air passages of the lungs) and make breathing difficult. Histamine can also cause some persons to have hives, with severe itching of the skin.


desloratadine is available only with your doctor's prescription.


Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .


Before Using desloratadine


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For desloratadine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to desloratadine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


desloratadine has been tested in children 6 months of age and older. In effective doses, the medicine has not been shown to cause different side effects or problems than it does in adults.


Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .


Geriatric


Desloratadine has been tested in patients 65 years of age and older and has not been shown to cause different side effects or problems in older people than it does in younger adults. However, older patients are more likely to have kidney or liver problems which may make them more sensitive to the effects of desloratadine. Your doctor may give you a different desloratadine dose if you have kidney or liver problems.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of desloratadine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Liver disease or

  • Kidney disease—Effects of desloratadine may be increased because of slower removal from the body.

  • Phenylketonuria (PKU)—The oral disintegrating tablets may contain aspartame, which can make your condition worse.

  • Slow metabolizers of desloratadine—May increase chances of unwanted effects

Proper Use of desloratadine


Dosing


The dose of desloratadine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of desloratadine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


For patients using the oral disintegrating tablet form of desloratadine:


  • Make sure your hands are dry.

  • Do not push the tablet through the foil backing of the package. Instead, gently peel back the foil backing and remove the tablet.

  • Immediately place the tablet on top of the tongue.

  • The tablet will dissolve in seconds, and you may swallow it with your saliva. You do not need to drink water or other liquid to swallow the tablet.

For patients using the syrup form of desloratadine: Use a calibrated measuring dropper or syringe to measure the direct dose for your child based on your doctor's instructions. Do not use a regular teaspoon. If you are unsure about how much of the syrup to give to your child, ask your doctor or pharmacist.


  • For oral dosage form (oral disintegrating tablets):
    • For symptoms of chronic hives:
      • Adults and children 12 years of age and older—5 milligrams (mg) once a day.

      • Children 6 to 11 years of age—2.5 mg once a day.

      • Children 4 to 6 years of age—Use and dose must be determined by your doctor.

      • Children and infants up to 4 years of age—Use is not recommended .


    • For symptoms of hay fever:
      • Adults and children 12 years of age and older—5 mg once a day.

      • Children 6 to 11 years of age—2.5 mg once a day.

      • Children 4 to 6 years of age—Use and dose must be determined by your doctor.

      • Children and infants up to 4 years of age—Use is not recommended .



  • For oral dosage form (tablets):
    • For symptoms of chronic hives:
      • Adults and children 12 years of age and older—5 mg once a day.

      • Children 4 to 12 years of age—Use and dose must be determined by your doctor.

      • Children and infants up to 4 years of age—Use is not recommended .


    • For symptoms of hay fever:
      • Adults and children 12 years of age and older—5 mg once a day.

      • Children 4 to 12 years of age—Use and dose must be determined by your doctor.

      • Children and infants up to 4 years of age—Use is not recommended .



  • For oral dosage form (syrup):
    • For symptoms of chronic hives:
      • Adults and children 12 years of age and older—2 teaspoonfuls (5 milligrams [mg] in 10 milliliters [mL]) once a day.

      • Children 6 to 11 years of age—1 teaspoonful (2.5 mg in 5 mL) once a day

      • Children 4 to 5 years of age—½ teaspoonful (1.25 mg in 2.5 mL) once a day

      • Children and infants up to 4 years of age—Use is not recommended .


    • For symptoms of hay fever:
      • Adults and children 12 years of age and older—2 teaspoonfuls (5 milligrams [mg] in 10 milliliters [mL]) once a day.

      • Children 6 to 11 years of age—1 teaspoonful (2.5 mg in 5 mL) once a day

      • Children 4 to 5 years of age—½ teaspoonful (1.25 mg in 2.5 mL) once a day

      • Children and infants up to 4 years of age—Use is not recommended .



Missed Dose


If you miss a dose of desloratadine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using desloratadine


If your symptoms do not improve within a few days or if they become worse, check with your doctor.


desloratadine may cause some people to become drowsy, dizzy, or less alert than they are normally. Make sure you know how you react to desloratadine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or are not alert.


desloratadine Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Rare
  • Anaphylaxis, such as, cough, difficulty swallowing, dizziness, fast heartbeat, hives, itching, puffiness or swelling of eyelids or around the eyes or face or lips or tongue, shortness of breath, skin rash, tightness in chest, unusual tiredness or weakness, wheezing

  • dyspnea, such as, shortness of breath, difficult or labored breathing, tightness in chest, wheezing

  • edema, such as, swelling

  • pruritus, such as, itching skin

  • rash

  • tachycardia, such as, fast, pounding, or irregular heartbeat or pulse

  • urticaria, such as, hives or welts, itching, redness of skin, skin rash.

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Headache

Less common
  • Dizziness

  • dry mouth

  • dysmenorrhea, such as, difficult or painful menstruation

  • dyspepsia, such as, acid or sour stomach, belching, heartburn, indigestion, stomach discomfort , upset or pain,

  • fatigue, such as, unusual tiredness or weakness

  • myalgia, such as, joint pain, swollen joints, muscle aching or cramping, muscle pains or stiffness, difficulty in moving

  • pharyngitis, such as, body aches or pain, congestion, cough, dryness or soreness of throat, fever, hoarseness, runny nose, tender swollen glands in neck, trouble in swallowing, voice changes.

  • somnolence, such as, sleepiness or unusual drowsiness

  • nausea

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: desloratadine side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More desloratadine resources


  • Desloratadine Side Effects (in more detail)
  • Desloratadine Use in Pregnancy & Breastfeeding
  • Desloratadine Drug Interactions
  • Desloratadine Support Group
  • 8 Reviews for Desloratadine - Add your own review/rating


  • Desloratadine Prescribing Information (FDA)

  • Desloratadine Professional Patient Advice (Wolters Kluwer)

  • Desloratadine Monograph (AHFS DI)

  • Desloratadine MedFacts Consumer Leaflet (Wolters Kluwer)

  • Clarinex Consumer Overview

  • Clarinex Prescribing Information (FDA)

  • Clarinex Reditabs Orally Disintegrating Tablets MedFacts Consumer Leaflet (Wolters Kluwer)



Compare desloratadine with other medications


  • Hay Fever
  • Urticaria

Tuesday, 14 September 2010

Dexa A




Dexa A may be available in the countries listed below.


Ingredient matches for Dexa A



Dexamethasone

Dexamethasone is reported as an ingredient of Dexa A in the following countries:


  • Japan

International Drug Name Search

Crisomet




Crisomet may be available in the countries listed below.


Ingredient matches for Crisomet



Lamotrigine

Lamotrigine is reported as an ingredient of Crisomet in the following countries:


  • Spain

International Drug Name Search

Monday, 13 September 2010

Fentanyl-1A Pharma




Fentanyl-1A Pharma may be available in the countries listed below.


Ingredient matches for Fentanyl-1A Pharma



Fentanyl

Fentanyl is reported as an ingredient of Fentanyl-1A Pharma in the following countries:


  • Austria

  • Germany

International Drug Name Search

Hypoten L




Hypoten L may be available in the countries listed below.


Ingredient matches for Hypoten L



Nitroprusside

Sodium Nitroprusside is reported as an ingredient of Hypoten L in the following countries:


  • South Africa

International Drug Name Search

Sunday, 5 September 2010

Fluconazolo ratiopharm




Fluconazolo ratiopharm may be available in the countries listed below.


Ingredient matches for Fluconazolo ratiopharm



Fluconazole

Fluconazole is reported as an ingredient of Fluconazolo ratiopharm in the following countries:


  • Italy

International Drug Name Search

Friday, 3 September 2010

CPS Pulver




CPS Pulver may be available in the countries listed below.


Ingredient matches for CPS Pulver



Polystyrene Sulfonic Acid

Polystyrene Sulfonic Acid calcium salt (a derivative of Polystyrene Sulfonic Acid) is reported as an ingredient of CPS Pulver in the following countries:


  • Austria

  • Germany

International Drug Name Search

Tuesday, 24 August 2010

Solaraze


Solaraze is a brand name of diclofenac topical, approved by the FDA in the following formulation(s):


SOLARAZE (diclofenac sodium - gel; topical)



  • Manufacturer: FOUGERA PHARMS

    Approval date: October 16, 2000

    Strength(s): 3% [RLD]

Has a generic version of Solaraze been approved?


No. There is currently no therapeutically equivalent version of Solaraze available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Solaraze. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
    Patent 5,639,738
    Issued: June 17, 1997
    Inventor(s): Falk; Rudolf Edgar & Asculai; Samuel Simon
    Assignee(s): Hyal Pharmaceutical Corporation
    A method of treating a mammal for a condition of the skin or exposed tissue selected from the group consisting of basal cell carcinoma and actinic keratosis is provided. The method consists essentially of topically administering to the site of the condition, more than once per day over a period of days sufficient to treat the condition, a non-toxic effective dosage amount of a composition consisting essentially of (a) a non-steroidal anti-inflammatory drug (NSAID) in an amount sufficient to block prostaglandin synthesis, (b) hyaluronic acid or a pharmaceutically acceptable salt thereof in an amount effective to transport said NSAID into the skin or exposed tissue at the site of the condition. The concentration of the hyaluronic add or salt thereof is between 1-3% by weight of the composition. The molecular weight of the hyaluronic acid or salt thereof is between 150,000 and 750,000 Daltons. A pharmaceutical excipient suitable for topical application is included. The NSAID in the composition may be diclofenac sodium.
    Patent expiration dates:

    • June 17, 2014
      ✓ 
      Patent use: TREATMENT OF ACTINIC KERATOSES




  • Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
    Patent 5,792,753
    Issued: August 11, 1998
    Inventor(s): Falk; Rudolf Edgar & Asculai; Samuel Simon
    Assignee(s): Hyal Pharmaceutical Corporation
    A topically administrable pharmaceutical composition is disclosed which comprises a therapeutically effective amount of a drug which inhibits prostaglandin synthesis, and an amount of a form of hyaluronic acid sufficient to transport the composition through the skin into the epidermis or dermis where the composition remains until discharged via the lymphatic system, wherein (a) the drug is 1-5% by weight of the composition, and (b) the form of hyaluronic acid is 1-3% by weight of the composition, has a molecular weight greater than about 150,000 daltons and less than 750,000 daltons, and is selected from the group consisting of hyaluronic acid and salts thereof.
    Patent expiration dates:

    • August 11, 2015




  • Treatment of conditions and disease
    Patent 5,852,002
    Issued: December 22, 1998
    Inventor(s): Falk; Rudolf Edgar & Asculai; Samuel S.
    Assignee(s): Hyal Pharmaceutical Corporation
    A combination for administration to a mammal which combination employs a therapeutically effective amount of a medicinal and/or therapeutic agent to treat a disease or condition and an amount of hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments and subunits of hyaluronic acid sufficient to facilitate the agent's penetration through the tissue (including scar tissue) at the site to be treated, through the cell membranes into the individual cells to be treated.
    Patent expiration dates:

    • June 17, 2014
      ✓ 
      Patent use: TREATMENT OF ACTINIC KERATOSES




  • Treatment of disease and conditions
    Patent 5,914,322
    Issued: June 22, 1999
    Inventor(s): Falk; Rudolf Edgar & Asculai; Samuel Simon
    Assignee(s): Hyal Pharmaceutical Corporation
    A topically applied transdermally penetrating systemic independent acting pharmaceutical combination and formulation for the treatment of a disease or condition of the skin and exposed tissue for example, basal cell carcinoma, the precancerous, often recurrent, actinic keratoses lesions, fungal lesions, "liver" spots and like lesions (found for the most part in the epidermis), squamous cell tumours, metastatic cancer of the breast to the skin, primary and metastatic melanoma in the skin, genital warts (condyloma acuminata) cervical cancer, and HPV (Human Papilloma Virus) including HPV of the cervix, psoriasis (both plaque-type psoriasis and nail bed psoriasis), corns on the feet and hair loss on the head of pregnant women, comprising, together with pharmaceutical excipients suitable for topical application, a therapeutically effective non-toxic amount of a drug which inhibits prostaglandin synthesis administered with, or carried in, an amount of hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and/or sub-units of hyaluronic acid (preferably hyaluronic acid and salts thereof) sufficient to facilitate the drug's penetration through the skin and tissue (including any scar tissue) at the site requiring treatment, to block prostaglandin synthesis.
    Patent expiration dates:

    • August 11, 2015




  • Treatment of conditions and disease
    Patent 5,929,048
    Issued: July 27, 1999
    Inventor(s): Falk; Rudolf Edgar & Asculai; Samuel S.
    Assignee(s): Hyal Pharmaceutical Corporation
    A combination for administration to a mammal which combination employs a therapeutically effective amount of a medicinal and/or therapeutic agent to treat a disease or condition and an amount of hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments and subunits of hyaluronic acid sufficient to facilitate the agent's penetration through the tissue (including scar tissue) at the site to be treated, through the cell membranes into the individual cells to be treated.
    Patent expiration dates:

    • June 17, 2014
      ✓ 
      Patent use: TREATMENT OF ACTINIC KERATOSES




  • Compositions comprising hyaluronic acid and drugs
    Patent 5,985,850
    Issued: November 16, 1999
    Inventor(s): Falk; Rudolf Edgar & Asculai; Samuel S.
    Assignee(s): Hyal Pharmaceuticals Corporation
    A dosage amount of a pharmaceutical composition comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid, wherein the form of hyaluronic acid is available to transport the agent from the point of administration to the site to be treated.
    Patent expiration dates:

    • August 11, 2015
      ✓ 
      Drug product



See also...

  • Solaraze Gel Consumer Information (Wolters Kluwer)
  • Solaraze Consumer Information (Cerner Multum)
  • Solaraze Topical Advanced Consumer Information (Micromedex)
  • Solaraze topical AHFS DI Monographs (ASHP)
  • Diclofenac Gel Consumer Information (Wolters Kluwer)
  • Diclofenac Patch Consumer Information (Wolters Kluwer)
  • Diclofenac Solution Consumer Information (Wolters Kluwer)
  • Diclofenac topical Consumer Information (Cerner Multum)
  • Diclofenac transdermal Consumer Information (Cerner Multum)
  • Voltaren Topical Advanced Consumer Information (Micromedex)
  • Diclofenac Topical Advanced Consumer Information (Micromedex)
  • Diclofenac Sodium topical AHFS DI Monographs (ASHP)

Thursday, 19 August 2010

Amoxilan




Amoxilan may be available in the countries listed below.


Ingredient matches for Amoxilan



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxilan in the following countries:


  • Austria

  • Venezuela

International Drug Name Search

Wednesday, 11 August 2010

Cobalin-H




In the US, Cobalin-H is a member of the drug class vitamins and is used to treat Schilling Test, Transcobalamin II Deficiency and Vitamin B12 Deficiency.

UK matches:

  • Cobalin-H injection (SPC)

Ingredient matches for Cobalin-H



Hydroxocobalamin

Hydroxocobalamin is reported as an ingredient of Cobalin-H in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Metorfan




Metorfan may be available in the countries listed below.


Ingredient matches for Metorfan



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Metorfan in the following countries:


  • Ecuador

  • Italy

International Drug Name Search

Tuesday, 10 August 2010

Pig Scour




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Pig Scour



Roxarsone

Roxarsone is reported as an ingredient of Pig Scour in the following countries:


  • United States

International Drug Name Search

Thursday, 5 August 2010

Preperidol




Preperidol may be available in the countries listed below.


Ingredient matches for Preperidol



Bromperidol

Bromperidol is reported as an ingredient of Preperidol in the following countries:


  • Japan

International Drug Name Search

Monday, 26 July 2010

Sohotin




Sohotin may be available in the countries listed below.


Ingredient matches for Sohotin



Loratadine

Loratadine is reported as an ingredient of Sohotin in the following countries:


  • Indonesia

International Drug Name Search

Sunday, 25 July 2010

Musgud




Musgud may be available in the countries listed below.


Ingredient matches for Musgud



Cyclobenzaprine

Cyclobenzaprine hydrochloride (a derivative of Cyclobenzaprine) is reported as an ingredient of Musgud in the following countries:


  • Taiwan

International Drug Name Search

Thursday, 22 July 2010

Kohle-Hevert




Kohle-Hevert may be available in the countries listed below.


Ingredient matches for Kohle-Hevert



Charcoal

Charcoal, Activated is reported as an ingredient of Kohle-Hevert in the following countries:


  • Germany

International Drug Name Search

Friday, 16 July 2010

Hydrocortisone Butyrate




Ingredient matches for Hydrocortisone Butyrate



Hydrocortisone

Hydrocortisone Butyrate (BANM, JAN, USAN) is known as Hydrocortisone in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
JANJapanese Accepted Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 15 July 2010

Indapamida Alter




Indapamida Alter may be available in the countries listed below.


Ingredient matches for Indapamida Alter



Indapamide

Indapamide is reported as an ingredient of Indapamida Alter in the following countries:


  • Portugal

International Drug Name Search

Wednesday, 14 July 2010

Cetirizine OGB




Cetirizine OGB may be available in the countries listed below.


Ingredient matches for Cetirizine OGB



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetirizine OGB in the following countries:


  • Indonesia

International Drug Name Search

Monday, 12 July 2010

Foxetin




Foxetin may be available in the countries listed below.


Ingredient matches for Foxetin



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Foxetin in the following countries:


  • Argentina

International Drug Name Search

Saturday, 26 June 2010

Alendronat Helvepharm




Alendronat Helvepharm may be available in the countries listed below.


Ingredient matches for Alendronat Helvepharm



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Alendronat Helvepharm in the following countries:


  • Switzerland

International Drug Name Search

Wednesday, 16 June 2010

Epirubicin Kabi




Epirubicin Kabi may be available in the countries listed below.


Ingredient matches for Epirubicin Kabi



Epirubicin

Epirubicin hydrochloride (a derivative of Epirubicin) is reported as an ingredient of Epirubicin Kabi in the following countries:


  • Germany

International Drug Name Search

Saturday, 12 June 2010

Doricum




Doricum may be available in the countries listed below.


Ingredient matches for Doricum



Fluocinolone

Fluocinolone Acetonide is reported as an ingredient of Doricum in the following countries:


  • Italy

Midazolam

Midazolam is reported as an ingredient of Doricum in the following countries:


  • Venezuela

Midazolam maleate (a derivative of Midazolam) is reported as an ingredient of Doricum in the following countries:


  • Venezuela

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Doricum in the following countries:


  • Italy

International Drug Name Search

Friday, 11 June 2010

Metotrexato Asofarma




Metotrexato Asofarma may be available in the countries listed below.


Ingredient matches for Metotrexato Asofarma



Methotrexate

Methotrexate sodium salt (a derivative of Methotrexate) is reported as an ingredient of Metotrexato Asofarma in the following countries:


  • Argentina

International Drug Name Search

Acido Alendronico Semanal Premium Pharma




Acido Alendronico Semanal Premium Pharma may be available in the countries listed below.


Ingredient matches for Acido Alendronico Semanal Premium Pharma



Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Acido Alendronico Semanal Premium Pharma in the following countries:


  • Spain

International Drug Name Search

Thursday, 10 June 2010

Cuprimine


Cuprimine is a brand name of penicillamine, approved by the FDA in the following formulation(s):


CUPRIMINE (penicillamine - capsule; oral)



  • Manufacturer: ATON

    Approved Prior to Jan 1, 1982

    Strength(s): 250MG [RLD]

Has a generic version of Cuprimine been approved?


No. There is currently no therapeutically equivalent version of Cuprimine available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cuprimine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Cuprimine.

See also...

  • Cuprimine Consumer Information (Wolters Kluwer)
  • Cuprimine Consumer Information (Cerner Multum)
  • Cuprimine Advanced Consumer Information (Micromedex)
  • Penicillamine Consumer Information (Wolters Kluwer)
  • Penicillamine Consumer Information (Cerner Multum)
  • Penicillamine Advanced Consumer Information (Micromedex)
  • Penicillamine AHFS DI Monographs (ASHP)